{"id":"https://openalex.org/W4225100577","doi":"https://doi.org/10.1016/j.ebiom.2022.104021","title":"Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial","display_name":"Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial","publication_year":2022,"publication_date":"2022-04-29","ids":{"openalex":"https://openalex.org/W4225100577","doi":"https://doi.org/10.1016/j.ebiom.2022.104021","pmid":"https://pubmed.ncbi.nlm.nih.gov/35500536","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9065877"},"language":"en","primary_location":{"id":"doi:10.1016/j.ebiom.2022.104021","doi":"https://doi.org/10.1016/j.ebiom.2022.104021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ebiom.2022.104021","pdf_url":"http://www.thelancet.com/article/S2352396422002055/pdf","source":{"id":"https://openalex.org/S2531685872","display_name":"EBioMedicine","issn_l":"2352-3964","issn":["2352-3964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.thelancet.com/article/S2352396422002055/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035514608","display_name":"Johannes Levin","orcid":"https://orcid.org/0000-0001-5092-4306","observed_orcids":["https://orcid.org/0000-0001-5092-4306"]},"institutions":[{"id":"https://openalex.org/I4210113080","display_name":"Munich Cluster for Systems Neurology","ror":"https://ror.org/025z3z560","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210113080","https://openalex.org/I62916508","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Johannes Levin","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, Ludwig-Maximilians-University Munich, Germany. Electronic address: levin@modag.net","Department of Neurology, Ludwig-Maximilians-University Munich, Germany","MODAG GmbH, Wendelsheim, Germany","Munich Cluster for Systems Neurology (SyNergy), Munich, Germany"],"raw_orcid":"https://orcid.org/0000-0001-5092-4306","affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, Ludwig-Maximilians-University Munich, Germany. Electronic address: levin@modag.net","institution_ids":["https://openalex.org/I4210113080","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Department of Neurology, Ludwig-Maximilians-University Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]},{"raw_affiliation_string":"Munich Cluster for Systems Neurology (SyNergy), Munich, Germany","institution_ids":["https://openalex.org/I4210113080"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037342869","display_name":"Nand Sing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nand Sing","raw_affiliation_strings":["Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085954466","display_name":"Sue Melbourne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sue Melbourne","raw_affiliation_strings":["Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Amber Morgan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amber Morgan","raw_affiliation_strings":["Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006730996","display_name":"Carla Mariner","orcid":"https://orcid.org/0000-0002-6857-4954","observed_orcids":["https://orcid.org/0000-0002-6857-4954"]},"institutions":[{"id":"https://openalex.org/I4405267629","display_name":"Quotient Sciences Limited (United Kingdom)","ror":"https://ror.org/03ncz2v38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267629"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carla Mariner","raw_affiliation_strings":["Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK"],"raw_orcid":"https://orcid.org/0000-0002-6857-4954","affiliations":[{"raw_affiliation_string":"Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham NG11 6JS, UK","institution_ids":["https://openalex.org/I4405267629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037609259","display_name":"Maria Grazia Spillantini","orcid":"https://orcid.org/0000-0002-8544-7332","observed_orcids":["https://orcid.org/0000-0002-8544-7332"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria Grazia Spillantini","raw_affiliation_strings":["Department of Clinical Neurosciences, University of Cambridge, The Clifford Allbutt Building, Cambridge, CB2 0AH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neurosciences, University of Cambridge, The Clifford Allbutt Building, Cambridge, CB2 0AH, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040714021","display_name":"Micha\u0142 W\u0119grzynowicz","orcid":"https://orcid.org/0000-0002-5082-9576","observed_orcids":["https://orcid.org/0000-0002-5082-9576"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210157213","display_name":"Mossakowski Medical Research Institute,  Polish Academy of Sciences","ror":"https://ror.org/05d3ntb42","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210157213","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["GB","PL"],"is_corresponding":false,"raw_author_name":"Michal Wegrzynowicz","raw_affiliation_strings":["Department of Clinical Neurosciences, University of Cambridge, The Clifford Allbutt Building, Cambridge, CB2 0AH, UK.; Laboratory of Molecular Basis of Neurodegeneration, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland","Department of Clinical Neurosciences, University of Cambridge, The Clifford Allbutt Building, Cambridge, CB2 0AH, UK","Laboratory of Molecular Basis of Neurodegeneration, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland"],"raw_orcid":"https://orcid.org/0000-0002-5082-9576","affiliations":[{"raw_affiliation_string":"Department of Clinical Neurosciences, University of Cambridge, The Clifford Allbutt Building, Cambridge, CB2 0AH, UK.; Laboratory of Molecular Basis of Neurodegeneration, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210157213","https://openalex.org/I99542240"]},{"raw_affiliation_string":"Department of Clinical Neurosciences, University of Cambridge, The Clifford Allbutt Building, Cambridge, CB2 0AH, UK","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Laboratory of Molecular Basis of Neurodegeneration, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland","institution_ids":["https://openalex.org/I4210157213","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035188600","display_name":"Jeffrey W. Dalley","orcid":"https://orcid.org/0000-0002-2282-3660","observed_orcids":["https://orcid.org/0000-0002-2282-3660"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Dalley","raw_affiliation_strings":["Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK; Department of Psychiatry, Hershel Smith Building for Brain and Mind Sciences, Addenbrooke's Hospital, Cambridge CB2 0SZ","Department of Psychiatry, Hershel Smith Building for Brain and Mind Sciences, Addenbrooke's Hospital, Cambridge CB2 0SZ","Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK; Department of Psychiatry, Hershel Smith Building for Brain and Mind Sciences, Addenbrooke's Hospital, Cambridge CB2 0SZ","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]},{"raw_affiliation_string":"Department of Psychiatry, Hershel Smith Building for Brain and Mind Sciences, Addenbrooke's Hospital, Cambridge CB2 0SZ","institution_ids":["https://openalex.org/I4210156194"]},{"raw_affiliation_string":"Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041582936","display_name":"Simon Langer","orcid":"https://orcid.org/0000-0002-9660-8058","observed_orcids":["https://orcid.org/0000-0002-9660-8058"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Langer","raw_affiliation_strings":["Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007435496","display_name":"Sergey Ryazanov","orcid":"https://orcid.org/0000-0002-2685-7956","observed_orcids":["https://orcid.org/0000-0002-2685-7956"]},"institutions":[{"id":"https://openalex.org/I4210131661","display_name":"Max Planck Institute for Biophysical Chemistry","ror":"https://ror.org/03e76ya46","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210131661","https://openalex.org/I4387154714"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sergey Ryazanov","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany; Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany; Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4210131661"]},{"raw_affiliation_string":"Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4210131661"]},{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102755842","display_name":"Andrei Leonov","orcid":"https://orcid.org/0000-0002-5586-9382","observed_orcids":["https://orcid.org/0000-0002-5586-9382"]},"institutions":[{"id":"https://openalex.org/I4210131661","display_name":"Max Planck Institute for Biophysical Chemistry","ror":"https://ror.org/03e76ya46","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210131661","https://openalex.org/I4387154714"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andrei Leonov","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany; Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany; Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4210131661"]},{"raw_affiliation_string":"Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4210131661"]},{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037375841","display_name":"Christian Griesinger","orcid":"https://orcid.org/0000-0002-1266-4344","observed_orcids":["https://orcid.org/0000-0002-1266-4344"]},"institutions":[{"id":"https://openalex.org/I4210131661","display_name":"Max Planck Institute for Biophysical Chemistry","ror":"https://ror.org/03e76ya46","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210131661","https://openalex.org/I4387154714"]},{"id":"https://openalex.org/I4387156107","display_name":"Multiscale Bioimaging","ror":"https://ror.org/05xy1nn52","country_code":"DE","type":"education","lineage":["https://openalex.org/I4387156107","https://openalex.org/I74656192"]},{"id":"https://openalex.org/I74656192","display_name":"University of G\u00f6ttingen","ror":"https://ror.org/01y9bpm73","country_code":"DE","type":"education","lineage":["https://openalex.org/I74656192"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Griesinger","raw_affiliation_strings":["Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany; Cluster of Excellence \"Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells\" (MBExC), University of G\u00f6ttingen, G\u00f6ttingen, Germany","Cluster of Excellence \u201cMultiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells\u201d (MBExC), University of G\u00f6ttingen, G\u00f6ttingen, Germany","Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany; Cluster of Excellence \"Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells\" (MBExC), University of G\u00f6ttingen, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4210131661","https://openalex.org/I4387156107","https://openalex.org/I74656192"]},{"raw_affiliation_string":"Cluster of Excellence \u201cMultiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells\u201d (MBExC), University of G\u00f6ttingen, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4387156107","https://openalex.org/I74656192"]},{"raw_affiliation_string":"Department of NMR based structural Biology, Max Planck Institute for Biophysical Chemistry, 37077, G\u00f6ttingen, Germany","institution_ids":["https://openalex.org/I4210131661"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057871177","display_name":"Felix Schmidt","orcid":"https://orcid.org/0000-0003-1307-1513","observed_orcids":["https://orcid.org/0000-0003-1307-1513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felix Schmidt","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029890870","display_name":"Daniel Weckbecker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Weckbecker","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060459230","display_name":"Kai Prager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Prager","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113707330","display_name":"Torsten Matthias","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Torsten Matthias","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009231408","display_name":"Armin Giese","orcid":"https://orcid.org/0000-0002-8238-4102","observed_orcids":["https://orcid.org/0000-0002-8238-4102"]},"institutions":[{"id":"https://openalex.org/I4405260960","display_name":"Institut f\u00fcr Neuropathologie","ror":"https://ror.org/04hhrpp03","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405260960","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Armin Giese","raw_affiliation_strings":["MODAG GmbH, Wendelsheim, Germany; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Germany. Electronic address: giese@modag.net","Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Germany","MODAG GmbH, Wendelsheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Germany. Electronic address: giese@modag.net","institution_ids":["https://openalex.org/I4405260960","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Germany","institution_ids":["https://openalex.org/I4405260960","https://openalex.org/I8204097"]},{"raw_affiliation_string":"MODAG GmbH, Wendelsheim, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5009231408","https://openalex.org/A5035514608"],"corresponding_institution_ids":["https://openalex.org/I4210113080","https://openalex.org/I4405260960","https://openalex.org/I8204097"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":10.2594,"has_fulltext":true,"cited_by_count":96,"citation_normalized_percentile":{"value":0.99076388,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"80","issue":null,"first_page":"104021","last_page":"104021"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anle138b","display_name":"anle138b","score":0.996999979019165},{"id":"https://openalex.org/keywords/alpha-synuclein-oligomers","display_name":"alpha-synuclein oligomers","score":0.8820000290870667},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.847000002861023},{"id":"https://openalex.org/keywords/synucleinopathies","display_name":"synucleinopathies","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6800000071525574},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.972000002861023},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.4440000057220459},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.6629999876022339},{"id":"https://openalex.org/keywords/multiple-ascending-dose","display_name":"multiple ascending dose","score":0.9700000286102295},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6729999780654907},{"id":"https://openalex.org/keywords/plasma-exposure","display_name":"plasma exposure","score":0.453000009059906},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.4950000047683716},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3959999978542328},{"id":"https://openalex.org/keywords/multiple-system-atrophy","display_name":"multiple system atrophy","score":0.5509999990463257},{"id":"https://openalex.org/keywords/dementia-with-lewy-bodies","display_name":"dementia with Lewy bodies","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9127169847488403},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7704446911811829},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6774172782897949},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.598983108997345},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5344699025154114},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5140248537063599},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5132527351379395},{"id":"https://openalex.org/C2777440831","wikidata":"https://www.wikidata.org/wiki/Q2376264","display_name":"Synucleinopathies","level":5,"score":0.5007753372192383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4948274493217468},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.43434134125709534},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41370314359664917},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.3036648631095886},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.19815948605537415},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1789618730545044},{"id":"https://openalex.org/C2781449126","wikidata":"https://www.wikidata.org/wiki/Q288591","display_name":"Alpha-synuclein","level":4,"score":0.09054294228553772},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000080874","descriptor_name":"Synucleinopathies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051844","descriptor_name":"alpha-Synuclein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052117","descriptor_name":"Benzodioxoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.1016/j.ebiom.2022.104021","doi":"https://doi.org/10.1016/j.ebiom.2022.104021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ebiom.2022.104021","pdf_url":"http://www.thelancet.com/article/S2352396422002055/pdf","source":{"id":"https://openalex.org/S2531685872","display_name":"EBioMedicine","issn_l":"2352-3964","issn":["2352-3964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"journal-article"},{"id":"pmid:35500536","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35500536","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EBioMedicine","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:9065877","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9065877/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EBioMedicine","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:2aeca4c5452945a2b232932da803dc99","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2aeca4c5452945a2b232932da803dc99","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EBioMedicine, Vol 80, Iss , Pp 104021- (2022)","raw_type":"article"},{"id":"pmh:oai:epub.ub.uni-muenchen.de:112075","doi":null,"is_oa":true,"landing_page_url":"http://nbn-resolving.de/urn:nbn:de:bvb:19-epub-112075-4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401845","display_name":"Open access LMU (Ludwid Maxmilian's Universitat Munchen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8204097","host_organization_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","host_organization_lineage":["https://openalex.org/I8204097"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"eBioMedicine","raw_type":"doc-type:article"},{"id":"pmh:oai:mediatum.ub.tum.de:node/1765612","doi":null,"is_oa":true,"landing_page_url":"https://mediatum.ub.tum.de/1765612","pdf_url":null,"source":{"id":"https://openalex.org/S4306400453","display_name":"mediaTUM \u2013 the media and publications repository of the Technical University Munich (Technical University Munich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I62916508","host_organization_name":"Technical University of Munich","host_organization_lineage":["https://openalex.org/I62916508"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:publications.goettingen-research-online.de:2/108672","doi":null,"is_oa":true,"landing_page_url":"https://mbexc.uni-goettingen.de/literature/publications/513","pdf_url":null,"source":{"id":"https://openalex.org/S4306401634","display_name":"GoeScholar  The Publication Server of the Georg-August-Universit\u00e4t G\u00f6ttingen (Georg-August-Universit\u00e4t G\u00f6ttingen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210122495","host_organization_name":"Asklepios Klinik St. Georg","host_organization_lineage":["https://openalex.org/I4210122495"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"journal_article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/337811","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/337811","pdf_url":null,"source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"essn: 2352-3964","raw_type":"Article"},{"id":"doi:10.17863/cam.85220","doi":"https://doi.org/10.17863/cam.85220","is_oa":true,"landing_page_url":"https://doi.org/10.17863/cam.85220","pdf_url":null,"source":{"id":"https://openalex.org/S7407050737","display_name":"Apollo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1016/j.ebiom.2022.104021","doi":"https://doi.org/10.1016/j.ebiom.2022.104021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ebiom.2022.104021","pdf_url":"http://www.thelancet.com/article/S2352396422002055/pdf","source":{"id":"https://openalex.org/S2531685872","display_name":"EBioMedicine","issn_l":"2352-3964","issn":["2352-3964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eBioMedicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1395390767","display_name":null,"funder_award_id":"G-1102","funder_id":"https://openalex.org/F4320320021","funder_display_name":"Parkinson's UK"},{"id":"https://openalex.org/G3975680159","display_name":null,"funder_award_id":"G-0701","funder_id":"https://openalex.org/F4320320021","funder_display_name":"Parkinson's UK"},{"id":"https://openalex.org/G4561920432","display_name":null,"funder_award_id":"G-1703","funder_id":"https://openalex.org/F4320320021","funder_display_name":"Parkinson's UK"}],"funders":[{"id":"https://openalex.org/F4320306136","display_name":"Michael J. Fox Foundation for Parkinson's Research","ror":"https://ror.org/03arq3225"},{"id":"https://openalex.org/F4320320021","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4225100577.pdf","grobid_xml":"https://content.openalex.org/works/W4225100577.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1559273977","https://openalex.org/W2034075546","https://openalex.org/W2077209471","https://openalex.org/W2155299862","https://openalex.org/W2175672482","https://openalex.org/W2338815822","https://openalex.org/W2587082207","https://openalex.org/W2623521763","https://openalex.org/W2754854078","https://openalex.org/W2773490123","https://openalex.org/W2779227034","https://openalex.org/W2785002530","https://openalex.org/W2888551398","https://openalex.org/W2898145665","https://openalex.org/W2901801746","https://openalex.org/W2911646467","https://openalex.org/W2950809148","https://openalex.org/W2965508550","https://openalex.org/W2966162733","https://openalex.org/W2973200211","https://openalex.org/W2980754698","https://openalex.org/W2989137916","https://openalex.org/W3027854502","https://openalex.org/W3047057015","https://openalex.org/W3146410983"],"related_works":["https://openalex.org/W2410337003","https://openalex.org/W2077209471","https://openalex.org/W7100287863","https://openalex.org/W7216817346","https://openalex.org/W6987130166","https://openalex.org/W2901801746","https://openalex.org/W7112213040","https://openalex.org/W7005317205","https://openalex.org/W3088615170","https://openalex.org/W3048516778"],"abstract_inverted_index":{"BACKGROUND:":[0],"Synucleinopathies":[1],"such":[2],"as":[3],"Parkinson":[4,273,300],"\u0301s":[5],"disease":[6],"(PD),":[7],"Dementia":[8],"with":[9,308],"Lewy":[10],"bodies":[11],"(DLB)":[12],"and":[13,24,42,77,95,171,198,227,281,318],"Multiple":[14],"System":[15],"Atrophy":[16],"(MSA)":[17],"are":[18,43],"characterized":[19],"by":[20,45,315,319],"deposition":[21],"of":[22,30,61,118,123,132,161,240,259,284],"misfolded":[23],"aggregated":[25],"\u03b1-synuclein.":[26],"Small":[27],"aggregates":[28],"(oligomers)":[29],"\u03b1-synuclein":[31],"have":[32],"been":[33],"shown":[34],"to":[35,100,108,140,234,238],"be":[36],"the":[37,116,121,173,207,241,265,270,292,320],"most":[38],"relevant":[39],"neurotoxic":[40],"species":[41],"targeted":[44],"anle138b,":[46],"an":[47],"orally":[48,149],"bioavailable":[49],"small":[50],"molecule":[51],"compound":[52],"which":[53],"shows":[54],"strong":[55],"disease-modifying":[56],"effects":[57],"in":[58,67,83,125,130,150,219,250,269,286,289,297,306],"animal":[59],"models":[60],"synucleinopathies.":[62,309],"METHODS:":[63],"Anle138b":[64],"was":[65,128,147,176,313],"studied":[66],"a":[68,298],"single-centre,":[69],"double-blind,":[70],"randomised,":[71],"placebo-controlled":[72],"single":[73],"ascending":[74,79],"dose":[75,80],"(SAD)":[76],"multiple":[78,257],"(MAD)":[81],"study":[82,208,312],"healthy":[84,126,194,221],"subjects.":[85],"Eligible":[86],"participants":[87,200],"were":[88,138,169,183,196,201,212,224,248,275],"randomly":[89],"assigned":[90],"(1:1":[91],"for":[92,97,325],"sentinel":[93],"subjects":[94,127],"1:5":[96],"main":[98],"group)":[99],"placebo":[101],"or":[102,144,158,163,231],"anle138b":[103,124,162,285],"(dose":[104],"range":[105],"50":[106],"mg":[107,110,134,157,160],"300":[109],"per":[111,135,209],"day),":[112],"respectively.":[113],"In":[114],"addition,":[115],"effect":[117],"food":[119],"on":[120],"pharmakokinetics":[122],"examined":[129],"doses":[131,258,287],"150":[133],"day.":[136],"Participants":[137],"randomized":[139,181],"treatment":[141],"sequence":[142],"(fed\u2192fasted)":[143],"(fasted\u2192fed).":[145],"Treatment":[146],"administered":[148],"hard":[151],"gelatine":[152],"capsules":[153],"containing":[154],"either":[155],"10":[156],"30":[159],"excipient":[164],"only.":[165],"The":[166,278],"primary":[167],"endpoints":[168],"safety":[170,280],"tolerability,":[172],"secondary":[174],"endpoint":[175],"pharmakokinetics.":[177],"Data":[178],"from":[179],"all":[180,205,228],"individuals":[182],"evaluated.":[184],"CLINICALTRIALS:":[185],"gov-identifier:":[186],"NCT04208152.":[187],"EudraCT-number:":[188],"2019-004218-33.":[189],"FINDINGS:":[190],",":[191],"2020":[192],"196":[193],"volunteers":[195],"screened":[197],"68":[199],"enrolled.":[202],"Of":[203],"these,":[204],"completed":[206],"protocol.":[210],"There":[211],"no":[213,243],"major":[214],"protocol":[215],"deviations.":[216],"Adverse":[217],"events":[218],"this":[220],"volunteer":[222],"trial":[223,242],"mostly":[225],"mild":[226],"fully":[229,266,293],"recovered":[230],"resolved":[232],"prior":[233],"discharge.":[235],"From":[236],"baseline":[237],"completion":[239],"medically":[244],"significant":[245],"individual":[246],"changes":[247],"observed":[249],"any":[251],"system":[252],"organ":[253],"class.":[254],"Already":[255],"at":[256],"200":[260],"mg,":[261],"exposure":[262,268],"levels":[263],"above":[264,291],"effective":[267,294],"MI2":[271],"mouse":[272,299],"model":[274,301],"observed.":[276],"INTERPRETATION:":[277],"favourable":[279],"PK":[282],"profile":[283],"resulting":[288],"exposures":[290],"plasma":[295],"level":[296],"warrant":[302],"further":[303],"clinical":[304],"trials":[305],"patients":[307],"FUNDING:":[310],"This":[311],"funded":[314],"MODAG":[316],"GmbH":[317],"Michael":[321],"J.":[322],"Fox":[323],"foundation":[324],"Parkinson's":[326],"Research.":[327]},"counts_by_year":[{"year":2026,"cited_by_count":22},{"year":2025,"cited_by_count":30},{"year":2024,"cited_by_count":24},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-04-30T00:00:00"}